1233025-78-9

Basic information

• Product Name: 8-Bromo-1-chloroisoquinoline
• Synonyms: 8-Bromo-1-chloroisoquinoline;1-Chloro-8-broMoisoquinoline;8-Bromo-1-chloro-2-azanaphthalene
• CAS NO: 1233025-78-9
• Molecular Formula: C₉H₅BrClN
• Molecular Weight: 242.4997
• EINECS: -0
• Mol File: 1233025-78-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 349.5±22.0 °C(Predicted)
• Appearance: /
• Density: 1.673±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 1.31±0.50(Predicted)
• CAS DataBase Reference: 8-Bromo-1-chloroisoquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Bromo-1-chloroisoquinoline(1233025-78-9)
• EPA Substance Registry System: 8-Bromo-1-chloroisoquinoline(1233025-78-9)

Safety Data

• Hazardous Substances Data: 1233025-78-9(Hazardous Substances Data)

Usage

General Description

8-Bromo-1-chloroisoquinoline is a chemical compound with the molecular formula C9H6BrClN that belongs to the class of organic compounds known as heteroaromatic compounds. It is a halogenated isoquinoline derivative, containing both bromine and chlorine atoms. 8-Bromo-1-chloroisoquinoline is mainly used in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable building block for the production of various biologically active compounds. Additionally, 8-Bromo-1-chloroisoquinoline has potential applications in the field of medicinal chemistry, particularly in drug discovery and development. It is of interest to researchers and industries looking to develop new molecules with therapeutic or agricultural benefits.

Upstream product

• 475994-58-2 8-bromo-2-oxidoisoquinolin-2-ium 
• 63927-22-0 8-bromo-isoquinoline 
• 475994-60-6 8-bromo-2H-isoquinolin-1-one 

Relevant articles and documents

LIGHT-EMITTING MATERIAL HAVING POLYCYCLIC LIGAND

PROBLEM TO BE SOLVED: To provide a metal complex which can adjust light-emitting complexion of an element more efficiently while maintaining an extremely narrow half value full width when being used as a light-emitting material in the electroluminescent element, lowers a drive voltage of the element or maintains a low voltage level, improves efficiency of the element, and extremely greatly improves a useful life of the element. SOLUTION: A metal complex includes a ligand having a structure for instance, of a following chemical compound 9. An electroluminescent element includes the metal complex. SELECTED DRAWING: None COPYRIGHT: (C)2022,JPOandINPIT

KRAS G12C INHIBITORS

The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

SUBSTITUTED TRIAZOLOPYRIDINES AND ANALOGS THEREOF

The present invention relates to substituted triazolopyridines and analogs thereof, the use of the compounds as phosphodiesterase 10 (PDE10) inhibitors for the treatment of PDE10-modulated disorders, to pharmaceutical compositions comprising the compounds.